Who is sponsoring NCT07136831?

NCT07136831 is sponsored by Assiut University.

What drugs are being tested in NCT07136831?

Interventions in NCT07136831: Primary Percutaneous Coronary Intervention (PPCI).

What condition does NCT07136831 study?

NCT07136831 studies MACE, In STEMI.

Is NCT07136831 still recruiting?

NCT07136831 is currently not yet recruiting. Last updated 22 August 2025.

Last reviewed 2025-08-22 · How we verify

NCT07136831

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

"Short-term Outcome in STEMI Patients Undergoing Primary PCI: A Comparative Study Between Rural and Urban Communities at Assiut University."

Not yet recruiting Last updated 22 August 2025

What this trial tests

trial testing Primary Percutaneous Coronary Intervention (PPCI) in MACE in 162 participants. Not yet recruiting.

Timeline

15 August 2025

Primary endpoint
15 October 2026

30 December 2026

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	162
Start date	15 August 2025
Primary completion	15 October 2026
Estimated completion	30 December 2026

Drugs / interventions tested

Primary Percutaneous Coronary Intervention (PPCI)

Conditions studied

MACE — all drugs for MACE →
In STEMI — all drugs for In STEMI →

Sponsor

Assiut University

Who can join

Adults 18 to 90, any sex, with MACE or In STEMI. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study aims to assess the short-term (3-month) clinical and echocardiographic outcomes of primary PCI among STEMI patients from rural versus urban areas in Upper Egypt. A special focus will be placed on identifying predictors of MACE. The findings may offer valuable insight into optimizing STEMI care pathways and support the development of regional STEMI networks across Egypt.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Primary Percutaneous Coronary Intervention (PPCI)

Trials testing the same drug.

NCT03266328 — Procedure and In-hospital Outcome of Patients Under 40 Years Old Undergoing Primary Percutaneous Coronary Intervention f · unknown

Other recruiting trials for MACE

Currently open trials in the same condition.

NCT06951867 — Tezspire Cardiac Events PASS · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07136831 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 22 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07136831.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing